A US citizen working with a humanitarian organisation in the Democratic Republic of Congo has tested positive for Bundibugyo virus, a strain of Ebola, the CDC confirmed on Friday, July 10.
The agency said it is coordinating with the patient’s employer, other federal agencies, and Congolese health authorities on contact tracing and risk assessments to identify anyone at high risk. It gave no further detail. The State Department said it was aware of the case and facilitating support for the American involved, declining to elaborate.
The patient was admitted to the special isolation unit at Frankfurt University Hospital in Germany at around 3 a.m. on Monday.
This is the second American
An earlier case involved Dr. Peter Stafford, an American missionary physician who tested positive in May after developing symptoms. His wife Dr. Rebekah Stafford, another physician, and the couple’s four children all under seven were monitored for infection. The family, resident in the DRC since 2021, was evacuated to Berlin, where Stafford was treated in quarantine. He recovered, tested negative, and returned to the US last month.
The numbers behind it
Congolese authorities declared the outbreak on May 15 after the virus had already been circulating undetected for weeks, according to the WHO.
The Africa CDC now describes it as the fastest-growing Ebola outbreak ever recorded on the continent: 1,830 confirmed cases and 648 deaths in the DRC, with further cases confirmed in neighbouring Uganda. It is the second-largest outbreak on record in the DRC.
Why this strain is different
Bundibugyo is the rare one. Unlike the Zaire strain that most Ebola vaccines and treatments were developed against, Bundibugyo has no approved vaccine and no approved treatment. Clinical trials for a treatment only began this month.
That’s the detail doing the heavy lifting here. The tools that ended previous outbreaks largely don’t apply to this one, and the response is falling back on the pre-vaccine playbook: isolation, contact tracing, and containment.
What’s making it worse
The response is fighting on several fronts at once. Armed conflict in eastern Congo the outbreak’s epicentre has pushed thousands of people to flee, carrying the virus with them. Health centres have been attacked. Community mistrust runs deep, and a funding shortfall has thinned the response further. An Ebola treatment centre was set on fire after residents clashed with authorities over a victim’s body.
The spread beyond Africa
The first case outside the continent was a humanitarian worker who tested positive in France after returning from a mission in the DRC the first ever reported there.
Both American cases follow the same pattern: aid workers infected in the DRC, then evacuated to European hospitals. No cases have been detected inside the US. The CDC puts the risk of spread to the US at very low, and the WHO says the risk of a global outbreak remains low Bundibugyo isn’t airborne and transmits through bodily fluids, which limits how far it travels outside close-contact settings.
The US has still tightened precautions: enhanced health screening for citizens returning from the region, and restricted entry for non-citizens coming from it.
Why Nigerians should pay attention
Nigeria has been here before the 2014 Lagos importation, brought in by a single traveller, remains one of the more instructive episodes in the country’s public health history, and it was contained largely on the strength of aggressive contact tracing rather than any vaccine.
That precedent matters more than usual now. With no approved vaccine or treatment for Bundibugyo, tracing and isolation are effectively the entire toolkit again. The reassuring part is that the same toolkit worked in 2014. The uncomfortable part is that the DRC has been doing exactly that for two months and the outbreak is still the fastest-growing the continent has recorded because the obstacles there aren’t medical. They’re conflict, funding and trust.
